What stage does Neo Kuma Ventures invest at?

Neo Kuma Ventures invests at the Pre-Seed, Seed, Series A stages.

What is Neo Kuma Ventures's typical check size?

Neo Kuma Ventures typically writes checks of $195K – $1.3M.

What sectors does Neo Kuma Ventures focus on?

Neo Kuma Ventures focuses on Biotech, Digital Health, Healthtech, Mental Health.

Where is Neo Kuma Ventures located?

Neo Kuma Ventures is headquartered in London, GB.

Neo Kuma Ventures

Venture capital

London · Pre-Seed–Series A · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Neo Kuma Ventures

783 people in our graph share verified history with the Neo Kuma Ventures team — schools, employers, funds. One of them is your warm intro.

Alice Pillarunlockedknows Clara Burtenshaw · together at University of Oxford (overlapped)

×4knows the team · via University of Oxford

×3knows the team · via New York University School of Law

×2knows the team · via Utrecht University

×2knows the team · via Stellenbosch University

✨ Fox Verdict

Investment thesis

The fund believes psychedelic compounds represent a paradigm shift in mental health treatment, with FDA breakthrough designations validating their potential to address root causes of mental illness affecting over 350 million patients globally. Investment focuses on the intersection of expanding clinical evidence, regulatory liberalization, and ecosystem development. The firm targets early-stage, science-driven ventures across compounds, clinic operations, digital therapeutics, and care platforms, leveraging expertise in biotech, pharmaceutical development, and policy advocacy to support founders from inception to scale.

Invests inBiotech Digital Health Healthtech Mental Health Europe Global London

Source: firm website, verified Aug 6, 2026.

Stage

Pre-Seed–Series A

Check

$195K – $1.3M

London, GB

Instruments

Equity

Founded

2021

Tracked investments

Team · 7 people

from the firm's website & public directories

Clara Burtenshaw· Founder and Investor· Lisbon, Portugalin

A biotech and life sciences investor with over 15 years in venture capital, private equity, operations, and deal execution. Recognized among the most influential women in psychedelics by Business Insider, with education from Oxford University and NYU School of Law.

Sean McLintock· Founder and Advisor· Londonin 𝕏

An entrepreneur and investor with expertise in wealth planning, trade finance, and family office experience. Previously involved with Andela, a high-growth technology company backed by Google Ventures.

Christina Sass· Advisory Board

An executive coach and co-founder and chair of Andela, where she raised over $181M and grew the organization to over 2,000 employees with a $50M run rate within six years. Prior experience includes roles at the MasterCard Foundation and the Clinton Global Initiative.

Dr. Peter Crane· Advisor, Chemical biology

A venture partner with healthcare investment and pharmaceutical expertise, holding a DPhil in Chemical Biology from Oxford University and a master's degree in chemistry from Warwick University.

Dr. Willem Hendrik Gispen· Advisor, Neuropharmacology

A medical biologist and neuroscientist holding distinguished academic positions including Head of the Department of Molecular Neurobiology and Rector Magnificus at Utrecht University, and Director of the Rudolf Magnus Institute for Neuroscience.

Fergus Argyle· Advisor

An experienced investor in public and private companies across credit and equity markets with broad expertise in technology, medical devices, pharmaceuticals, and biologics. Career includes senior roles at Blackrock and boutique investment firms in London and Asia.

Lomax Ward· Advisory Board

Co-founder and general partner at Outsized Ventures focused on human health. Previously a healthcare and life sciences investor at White Cloud and a corporate lawyer at Slaughter and May.

What they invest in

from 2 of 2 portfolio companies

Digital Health ×2Mental Health ×2Medical Devices ×1Wellness & Fitness ×1

Investments · 2 tracked

founders shown can be your intro path

Journey Clinicaljourneyclinical.com in 𝕏Sep 2021 · $3M

Journey Clinical provides ketamine-assisted psychotherapy (KAP) for depression, anxiety, and PTSD, partnering patients with licensed therapists and medical teams while coordinating with major insurance providers.

Digital HealthMedical DevicesMental Health

Jonathan Sabbagh(Co-founder & Executive Chairman of the Board)in Myriam Barthes(Co-founder & CEO)in

Co-investorsAble Partners AlleyCorp Coalition Operators Fifty Years Mantis Capital PROOF +5 more

Wavepathswavepaths.com in 𝕏Oct 2021 · $4.5M

Wavepaths develops adaptive therapeutic music designed to support mental health and wellness practitioners in their sessions.

Digital HealthMental HealthWellness & Fitness

Mendel Kaelen(Founder & CEO)in

Co-investorsMITON Reflex Capital LIONHEART VENTURES Palo Santo

Frequently asked questions

What stage does Neo Kuma Ventures invest at?: Neo Kuma Ventures invests at the Pre-Seed, Seed, Series A stages.
What is Neo Kuma Ventures's typical check size?: Neo Kuma Ventures typically writes checks of $195K – $1.3M.
What sectors does Neo Kuma Ventures focus on?: Neo Kuma Ventures focuses on Biotech, Digital Health, Healthtech, Mental Health.
Where is Neo Kuma Ventures located?: Neo Kuma Ventures is headquartered in London, GB.

Media · Podcasts & interviews

featuring the team

Advancements in psychedelic therapy - Expert Talk with Sean McLintock , Neo Kuma Ventures

Kalkine Media · Sean McLintock

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

MedMountain Ventures

MedMountain Ventures (MMV) is an early-stage healthcare investment firm founded by board-certified physicians and seasoned healthcare operators, backing companies that improve patient outcomes and reshape how care is delivered, financed, and accessed.

$500K – $5M

Mystic Ventures

Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.

LongeVC

LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.

Foreground Capital

Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.